登录 |  中文
首页 / 新闻 / Photo Gallery

Photo Gallery

CITTC and ITH sign MOU

来源: 时间:2014.03.10

December 6th, China International Technology Transfer Center (CITTC) and Immune Therapy Holdings AB (ITH) jointly signed a Memorandum of Understanding at Beijing. Mr. Shi Daxing, Deputy Director of the Beijing Technology Exchange and Promotion Center (BTEC), Mr. Hans Glise, Professor of Karolinska Institutet attended the signing ceremony and delivered keynote addresses.
The MoU includes items for cooperative effort to develop and strengthen the collaboration and mutual benefit within the field of medical technology transfer and transaction.
Immune Therapy Holdings AB (ITH) is an innovation-driven medical research and development company based at the Karolinska Institutet in Stockholm, Sweden. ITH’s subsidiary companies are developing highly innovative treatments and diagnostics utilizing the latest understanding of immunological mechanisms from research groups at Karolinska Institutet. The ITH portfolio includes therapeutics and diagnostics for immune mediated inflammatory diseases (IMIDs), cancers and HIV.

分享:  

Copyright © 2014    国际技术转移协作网络    京ICP备12048104号-4

北京市朝阳区芍药居北里101号世奥国际中心A座 1117室

联系我们:010-84351699    关于我们